阻塞性睡眠呼吸暂停与心房颤动的关联及持续气道正压通气治疗:综述
本综述汇总观察性数据显示,阻塞性睡眠呼吸暂停(OSA)在房颤患者中患病率高达21%–74%,可通过急性电生理改变与长期结构重构促进房颤发生并降低导管消融及抗心律失常药物疗效;持续气道正压通气(CPAP)在非随机研究中有助于电复律及消融后维持窦性心律,但仍需随机临床试验证实。
要点
- 房颤患者中OSA患病率21%–74%,多数无日间嗜睡,节律控制策略前可考虑睡眠监测。
- OSA通过急性电生理改变与长期结构重构促进房颤触发与维持。
- 非随机研究示CPAP有助电复律及消融后维持窦律,尚待随机试验证实。
核心结论
- 非随机研究提示CPAP治疗OSA可能有助于房颤患者电复律后维持窦性心律并提高导管消融成功率。
- 需随机临床试验证实OSA与房颤的关联、OSA治疗获益及常规筛查治疗的必要性与成本效益。
研究设计与样本
- 综述类文章,汇总人群研究及房颤患者中OSA患病率、机制与治疗相关的观察性及非随机研究数据。
主要发现
- OSA患病率在人群研究中为3%–49%,在房颤患者中为21%–74%。
- OSA通过急性短暂呼吸暂停相关心房电生理改变、间歇性去氧复氧、胸腔内压变化及交感迷走激活促进房颤触发。
- 长期反复OSA发作最终与心房结构重构及电传导改变相关。
- 观察性数据显示OSA降低导管消融及抗心律失常药物疗效。
- 非随机研究显示CPAP治疗有助于电复律及导管消融后维持窦性心律。
关键数值与推荐
- 房颤患者中OSA患病率21%–74%,多数不报告日间嗜睡,节律控制策略前睡眠监测可能合理。
- 尚不明确应采用何种睡眠呼吸暂停指标判定严重程度并指导房颤患者治疗。
临床怎么用
- 对考虑节律控制策略的房颤患者,可考虑睡眠监测评估OSA。
- 房颤合并OSA患者行电复律或导管消融后,CPAP治疗可能有助于维持窦性心律。
- OSA诊治需电生理、心内科与睡眠专科密切跨学科协作。
局限性
- CPAP获益主要来自非随机研究,尚缺乏随机临床试验证实。
- 尚不明确判定OSA严重程度及指导房颤患者治疗的睡眠呼吸暂停指标。
- 常规OSA筛查与治疗的必要性及成本效益尚待验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Obstructive sleep apnea (OSA) is the most common clinically significant breathing abnormality during sleep. It is highly prevalent among patients with atrial fibrillation (AF), and it promotes arrhythmogenesis and impairs treatment efficacy. OBSERVATIONS: The prevalence of OSA ranges from 3% to 49% in population-based studies and from 21% to 74% in patients with AF. Diagnosis and treatment of OSA in patients with AF requires a close interdisciplinary collaboration between electrophysiologists, cardiologists, and sleep specialists. Because the prevalence of OSA is high in patients with AF and most do not report daytime sleepiness, sleep-study evaluation may be reasonable for patients being considered for rhythm control strategy. Acute, transient apnea-associated atrial electrophysiological changes and increased occurrence of AF triggers associated with short episodes of intermittent deoxygenation and reoxygenation, intrathoracic pressure changes during obstructed breathing efforts, and sympathovagal activation combine to create a stimulus for AF triggers and a complex and dynamic substrate for AF during sleep. Repeated episodes of long-term OSA are eventually associated with structural remodeling and changes in electrical conduction in the atrium. Observational data suggest OSA reduces the efficacy of catheter-based and pharmacological antiarrhythmic therapy. Nonrandomized studies have shown that treatment of OSA by continuous positive airway pressure can help to maintain a sinus rhythm after electrical cardioversion and catheter ablation in patients with AF. However, it remains unclear which sleep apnea metric should be used to determine severity and guide such treatment in patients with AF. CONCLUSIONS AND RELEVANCE: Data from nonrandomized studies of patients with AF suggest that treatment of OSA by continuous positive airway pressure may help to maintain sinus rhythm after electrical cardioversion and improve catheter ablation success rates. Randomized clinical trials are needed to confirm the association between OSA and AF the benefits of treatment of OSA and the need for and cost-effectiveness of routine OSA screening and treatment.
引用
- Linz D, McEvoy RD, Cowie MR, et al. Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review. JAMA Cardiol. 2018. PMID: 29541763. doi:10.1001/jamacardio.2018.0095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。